4.6 Article

Chronic Anterior Uveitis in Children: Psychosocial Challenges for Patients and Their Families

期刊

AMERICAN JOURNAL OF OPHTHALMOLOGY
卷 191, 期 -, 页码 XVI-XXIV

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ajo.2018.03.028

关键词

-

资金

  1. ARTHRITIS FOUNDATION PACIFIC REGION
  2. UCLA Stein Eye Institute Maggi Kelly Vision Fund
  3. Skirball Foundation, New York, New York
  4. National Eye Institute [K23EY021760]
  5. Rheumatology Research Foundation, Atlanta, Georgia
  6. Cincinnati Children's Hospital Medical Center Research Innovation and Pilot Fund

向作者/读者索取更多资源

PURPOSE: To describe issues of concern to childrenwith chronic anterior uveitis; to consider the psychological impact of chronic anterior uveitis on children's lives; and to understand the effect of a child's chronic illness on other family members. DESIGN: Expert commentary. METHODS: Author experiences were supplemented by a review of pertinent medical literature and by consideration of content from semi-structured, separate patient and parent interviews. RESULTS: Vision loss and the fear of blindness are not the only stressors for children with chronic anterior uveitis and their families; of additional concern are the burdens of examinations and treatment regimens, as well as drug toxicities. Children with chronic anterior uveitis experience medical, academic, interpersonal, psychological, and developmental challenges. The impact of disease extends to other members of a patient's family as well; parents experience challenges in similar domains. Problems with adherence to medical regimens are common. Both the disease and its treatment affect quality of life, and can interfere with successful management of disease and transition to autonomy in adulthood, as reported for other chronic conditions. Coping processes vary greatly between different families. CONCLUSIONS: Eye examinations and the rigors of long-term treatment often influence the psychosocial health of patients and families; physicians who are aware of these issues can help patients and families cope with chronic illness and may improve outcomes. Further psychosocial research to understand the experiences of children dealing with chronic anterior uveitis is warranted; this commentary can serve as a foundation for development of age- and disease-specific research questions. (C) 2018 Elsevier Inc. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Ophthalmology

S100 Proteins, Cytokines, and Chemokines as Tear Biomarkers in Children with Juvenile Idiopathic Arthritis-associated Uveitis

Sheila T. Angeles-Han, Virginia Miraldi Utz, Sherry Thornton, Grant Schulert, Jackeline Rodriguez-Smith, Adam Kauffman, Alyssa Sproles, Najima Mwase, Theresa Hennard, Alexei Grom, Mekibib Altaye, Gary N. Holland

Summary: In this study, inflammatory biomarkers in tears were successfully detected in children with JIA-U, with IL-8, sICAM-1, and S100A12 identified as potential biomarkers for uveitis activity.

OCULAR IMMUNOLOGY AND INFLAMMATION (2021)

Article Rheumatology

Uveitis in Children and Adolescents

Margaret H. Chang, Jessica G. Shantha, Jacob J. Fondriest, Mindy S. Lo, Sheila T. Angeles-Han

RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2021)

Article Rheumatology

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging

Karen B. Onel, Daniel B. Horton, Daniel J. Lovell, Susan Shenoi, Carlos A. Cuello, Sheila T. Angeles-Han, Mara L. Becker, Randy Q. Cron, Brian M. Feldman, Polly J. Ferguson, Harry Gewanter, Jaime Guzman, Yukiko Kimura, Tzielan Lee, Katherine Murphy, Peter A. Nigrovic, Michael J. Ombrello, C. Egla Rabinovich, Melissa Tesher, Marinka Twilt, Marisa Klein-Gitelman, Fatima Barbar-Smiley, Ashley M. Cooper, Barbara Edelheit, Miriah Gillispie-Taylor, Kimberly Hays, Melissa L. Mannion, Rosemary Peterson, Elaine Flanagan, Nadine Saad, Nancy Sullivan, Ann Marie Szymanski, Rebecca Trachtman, Marat Turgunbaev, Keila Veiga, Amy S. Turner, James T. Reston

Summary: This study provides recommendations for the management of juvenile idiopathic arthritis, focusing on nonpharmacologic therapies, medication monitoring, immunizations, and imaging. The guideline emphasizes the importance of improving patient quality of life and involving patients and caregivers in decision-making. However, the evidence quality for all recommendations is low.

ARTHRITIS CARE & RESEARCH (2022)

Article Rheumatology

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis

Karen B. Onel, Daniel B. Horton, Daniel J. Lovell, Susan Shenoi, Carlos A. Cuello, Sheila T. Angeles-Han, Mara L. Becker, Randy Q. Cron, Brian M. Feldman, Polly J. Ferguson, Harry Gewanter, Jaime Guzman, Yukiko Kimura, Tzielan Lee, Katherine Murphy, Peter A. Nigrovic, Michael J. Ombrello, C. Egla Rabinovich, Melissa Tesher, Marinka Twilt, Marisa Klein-Gitelman, Fatima Barbar-Smiley, Ashley M. Cooper, Barbara Edelheit, Miriah Gillispie-Taylor, Kimberly Hays, Melissa L. Mannion, Rosemary Peterson, Elaine Flanagan, Nadine Saad, Nancy Sullivan, Ann Marie Szymanski, Rebecca Trachtman, Marat Turgunbaev, Keila Veiga, Amy S. Turner, James T. Reston

Summary: This study provides updated guidelines for pharmacologic management of juvenile idiopathic arthritis (JIA), focusing on specific types of JIA and treatment options. The recommendations are based on low-quality evidence and are conditional in nature.

ARTHRITIS CARE & RESEARCH (2022)

Article Rheumatology

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging

Karen B. Onel, Daniel B. Horton, Daniel J. Lovell, Susan Shenoi, Carlos A. Cuello, Sheila T. Angeles-Han, Mara L. Becker, Randy Q. Cron, Brian M. Feldman, Polly J. Ferguson, Harry Gewanter, Jaime Guzman, Yukiko Kimura, Tzielan Lee, Katherine Murphy, Peter A. Nigrovic, Michael J. Ombrello, C. Egla Rabinovich, Melissa Tesher, Marinka Twilt, Marisa Klein-Gitelman, Fatima Barbar-Smiley, Ashley M. Cooper, Barbara Edelheit, Miriah Gillispie-Taylor, Kimberly Hays, Melissa L. Mannion, Rosemary Peterson, Elaine Flanagan, Nadine Saad, Nancy Sullivan, Ann Marie Szymanski, Rebecca Trachtman, Marat Turgunbaev, Keila Veiga, Amy S. Turner, James T. Reston

Summary: This guideline provides recommendations for the management of juvenile idiopathic arthritis, focusing on nonpharmacologic therapies, medication monitoring, immunizations, and imaging. Recommendations include physical therapy and occupational therapy interventions, a healthy diet, medication monitoring, immunizations, and shared decision-making with patients/caregivers.

ARTHRITIS & RHEUMATOLOGY (2022)

Article Rheumatology

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis

Karen B. Onel, Daniel B. Horton, Daniel J. Lovell, Susan Shenoi, Carlos A. Cuello, Sheila T. Angeles-Han, Mara L. Becker, Randy Q. Cron, Brian M. Feldman, Polly J. Ferguson, Harry Gewanter, Jaime Guzman, Yukiko Kimura, Tzielan Lee, Katherine Murphy, Peter A. Nigrovic, Michael J. Ombrello, C. Egla Rabinovich, Melissa Tesher, Marinka Twilt, Marisa Klein-Gitelman, Fatima Barbar-Smiley, Ashley M. Cooper, Barbara Edelheit, Miriah Gillispie-Taylor, Kimberly Hays, Melissa L. Mannion, Rosemary Peterson, Elaine Flanagan, Nadine Saad, Nancy Sullivan, Ann Marie Szymanski, Rebecca Trachtman, Marat Turgunbaev, Keila Veiga, Amy S. Turner, James T. Reston

Summary: This article provides updated guidelines for the pharmacologic management of juvenile idiopathic arthritis (JIA), focusing on different forms of JIA and providing recommendations for treatment and tapering of medications. The evidence for these recommendations is generally low quality, but the inclusion of patients and caregivers in the decision-making process strengthens the relevance and applicability of the guideline.

ARTHRITIS & RHEUMATOLOGY (2022)

Letter Rheumatology

Relapse and Remission in Children With Chronic Noninfectious Uveitis Treated With Methotrexate

Courtney McCracken, Jessica G. Shantha, Steven Yeh, Kirsten Jenkins, Kelly A. Rouster-Stevens, Scott R. Lambert, Sampath Prahalad, Carolyn Drews-Botsch, Sheila T. Angeles-Han

JOURNAL OF RHEUMATOLOGY (2022)

Editorial Material Rheumatology

Screening, Monitoring, and Treating Children With Juvenile Idiopathic Arthritis-associated Uveitis: Visualizing Better Outcomes

Sheila T. Angeles-Han, Sunil K. Srivastava

JOURNAL OF RHEUMATOLOGY (2023)

Review Immunology

Challenges and management of childhood noninfectious chronic uveitis

Ilaria Maccora, Edoardo Marrani, Ilaria Pagnini, Maria Vincenza Mastrolia, Cinzia de Libero, Roberto Caputo, Gabriele Simonini

Summary: Childhood uveitis is a serious condition that can lead to blindness if not properly recognized and treated. This review discusses the main causes, diagnostic approach, risk factors, and difficulties in eye examination for childhood uveitis. The treatment options for childhood uveitis are also discussed in terms of choice, timing, and withdrawal.

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2023)

Editorial Material Immunology

Therapeutic potential of JAK inhibitors in juvenile idiopathic arthritis-associated uveitis

Ilaria Maccora, Preston Land, Virginia Miraldi Utz, Sheila T. Angeles-Han

EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2023)

Meeting Abstract Ophthalmology

Functional and Psychosocial Impact of Eye Disease in Pediatric Ebola Survivors, Sierra Leone

Dominick Canady, Caleb Hartley, Amy Cassedy, Chris Miller, Sheila T. Angeles-Han, Matthew Jusu Vandy, Gilberte Bastien, Natalie Weil, Steven Yeh, Jessica Shantha

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2021)

Meeting Abstract Ophthalmology

Assessing Visual Function and Quality of Life in Children with JIA and JIA-Uveitis Younger than 7 years Old

Jacob Fondriest, Amy Cassedy, Theresa Hennard, Carolyn Drews-Botsch, Jessi Lipscomb, Courtney McCracken, Joseph McDonald, Sampath Prahalad, Jessica Shantha, Virginia Utz, Steven Yeh, Sheila T. Angeles-Han

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2021)

Article Rheumatology

Prevalence of autoimmune diseases and other associated conditions in children and young adults with juvenile idiopathic arthritis

Daniel J. Lovell, Bin Huang, Chen Chen, Sheila T. Angeles-Han, Teresa A. Simon, Hermine Brunner

Summary: This study compared the prevalence of multiple coexisting autoimmune diseases in patients with juvenile idiopathic arthritis (JIA) and a general paediatric (GP) patient population. Results showed that JIA patients had a higher prevalence of a large number of coexisting autoimmune diseases compared to the GP population, with 53.8% of the evaluated conditions having significantly higher prevalence in the JIA cohort.

RMD OPEN (2021)

Meeting Abstract Rheumatology

Comparing S100 Proteins and Cytokine Levels in Tears Based on Uveitis Activity Laterality in Children with JIA-associated Uveitis and Non-JIA-U

Jackeline Rodriguez-Smith, Virginia Miraldi Utz, Amy Cassedy, Sherry Thornton, Grant Schulert, Alyssa Sproles, Najima Mwase, Theresa Hennard, Mekibib Altaye, Alexei Grom, Sheila Angeles-Han

ARTHRITIS & RHEUMATOLOGY (2020)

Meeting Abstract Rheumatology

Practice Patterns for Tapering Medications in the Treatment of JIA-associated Uveitis

Ivan Foeldvari, Jens Klotsche, Sheila Angeles-Han, Jordi Anton, Gabriele Simonini, Nadine Groesch, Jean Baer

ARTHRITIS & RHEUMATOLOGY (2020)

Editorial Material Ophthalmology

United States Regulatory Approval of Topical Treatments for Dry Eye

David Cui, Ian J. Saldanha, Gavin Li, Priya M. Mathews, Michael X. Lin, Esen K. Akpek

Summary: This article reports on the heterogeneity in methodology of clinical trials submitted to the US Food and Drug Administration for approval of topical dry eye treatments. Multiple outcome measures were used in these trials, highlighting the need for standardized assessment tools to optimize the evaluation and comparison of therapeutic benefits.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2024)

Article Ophthalmology

Disparities in Promotion and Retention Rates Among Underrepresented in Medicine Faculty in US Ophthalmology Departments

Adanna Udeh, Dana Huh, Terri Young, O'rese Knight, Fasika Woreta

Summary: This study examines the rates and trends of faculty promotions within the field of ophthalmology, with a focus on the rates of promotion among underrepresented in medicine (URiM) faculty. The results show that Black faculty had lower promotion rates and were more likely to leave academic medicine, highlighting the need for strategies and policies to address equity in promotion rates and retention of URiM faculty in academic ophthalmology.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2024)

Article Ophthalmology

Drusen and Other Retinal Findings in People With IgA Glomerulonephritis

Ursula Greferath, Erica Fletcher, Judy Savige, Heather G. Mack

Summary: Retinal drusen are uncommon in IgA nephropathy, but they resemble drusen found in age-related macular degeneration. The IgA-staining deposits in the drusen are likely related to systemic deposition of IgA. The nature of cystic spaces in the drusen is still unknown. Further research on the retinas of people with glomerulonephritis is recommended.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2024)

Article Ophthalmology

Association Between Vision Difficulty and Sociodemographic Factors in Children: A Population-Based Analysis

Andrew Mihalache, Ryan S. Huang, Nikhil S. Patil, Marko M. Popovic, Ashwin Mallipatna, Peter J. Kertes, Rajeev H. Muni, Radha P. Kohly

Summary: This study examines sociodemographic predictors of poor vision in children and adolescents in the US. The findings suggest that factors such as affordability of medical care, public health insurance, age, and parental education level are associated with vision difficulty. Addressing these disparities through public health policies is crucial for achieving equity in vision health.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2024)

Article Ophthalmology

IMPG2-Related Maculopathy

Johannes Birtel, Richard Caswell, Samantha R. De Silva, Philipp Herrmann, Salwah Rehman, Andrew J. Lotery, Omar A. Mahroo, Michel Michaelides, Andrew R. Webster, Robert E. Maclaren, Peter Charbel Issa

Summary: The study investigated the phenotype, variability, and penetrance of IMPG2-related maculopathy. The results showed that mono-allelic IMPG2 variants could result in haploinsufficiency manifesting as a maculopathy with variable penetrance and expressivity. Family members of patients with IMPG2-related retinitis pigmentosa may also present with vitelliform lesions. The maculopathy is usually limited to the fovea and is associated with moderate visual impairment.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2024)

Article Ophthalmology

Development and Validation of a Novel Mobility Test for Rod-Cone Dystrophies: From Reality to Virtual Reality

Colas Nils Authie, Mylene Poujade, Alireza Talebi, Alexis Defer, Ariel Zenouda, Cecilia Coen, Saddek Mohand-Said, Philippe Chaumet-Riffaud, Isabelle Audo, Jose-Alain Sahel

Summary: MOST has been validated as a reliable mobility test for measuring the movement ability of patients with vision impairments in both real and virtual environments.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2024)

Article Ophthalmology

Characterization of Ocular Injuries Caused by Orbeez Hydrated Gel Pellet Projectiles: Clinical Insights and Implications

Maria Krisch, Jordan Ueberroth, Neha Gupta, Stephen Merriam, Mark p. Breazzano

Summary: Orbeez-related ocular trauma can lead to severe visual morbidity and various intraocular sequelae. Adolescents may be at higher risk for posterior segment complications. Elevated IOP and hyphema at initial presentation may indicate a need for more aggressive interventions.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2024)

Article Ophthalmology

Validation of a Published Model to Reduce Burden of Retinopathy of Prematurity Screening

Jaron Pruett, Kelly Ruland, Sean Donahue

Summary: The study aimed to validate or refute the hypothesis that infants with birthweight over 750 g and gestational age over 27 weeks, who did not have retinopathy of prematurity (ROP) at 37 weeks, would not develop treatable ROP. The findings of the study supported the termination of examination at 37 weeks in infants meeting these criteria, as the value of continued screening was minimal.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2024)

Article Ophthalmology

Impact of Gender and Underrepresented in Medicine Status on Research Productivity Among Ophthalmology Residency Applicants

Emily Sun, Jing Tian, Loaah Eltemsah, Divya Srikumaran, Grace Sun, Jessica Chow, Fasika Woreta

Summary: This study aims to evaluate the research productivity of ophthalmology residency applicants and identify differences in productivity based on gender and race. The findings reveal that women have similar or higher research outputs compared to men, while self-identified underrepresented in medicine (URiM) students have lower research outputs in ophthalmology. Therefore, greater mentorship and support for URiM students are needed to promote the recruitment of diverse trainees in ophthalmology programs.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2024)

Article Ophthalmology

The Association Between Frailty and Visual Field Loss in US Adults

Isaac A. Bernstein, Ann Caroline Fisher, Kuldev Singh, Sophia Y. Wang

Summary: This study aims to investigate the association between visual field loss and frailty in a nationally representative cohort of US adults.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2024)